We present here the co-expressed protein-protein interactions algorithm. In addition to minimizing correlation-causality imbalance and contextualizing protein-protein interactions to the investigated systems, it combines protein-protein interactions and protein co-expression networks to identify differentially correlated functional modules. To test the algorithm, we processed a set of proteomic profiles from different brain regions of controls and subjects affected by idiopathic Parkinson's disease or carrying a GBA1 mutation. Its robustness was supported by the extraction of functional modules, related to translation and mitochondria, whose involvement in Parkinson's disease pathogenesis is well documented. Furthermore, the selection of hubs and bottlenecks from the weightedprotein-protein interactions networks provided molecular clues consistent with the Parkinson pathophysiology. Of note, like quantification, the algorithm revealed less variations when comparing disease groups than when comparing diseased and controls. However, correlation and quantification results showed low overlap, suggesting the complementarity of these measures. An observation that opens the way to a new investigation strategy that takes into account not only protein expression, but also the level of coordination among proteins that cooperate to perform a given function.

Clinical Proteomics Laboratory Elixir Infrastructure Institute for Biomedical Technologies National Research Council F lli Cervi 93 20054 Segrate Milan Italy

Division of Neuroscience IRCCS San Raffaele Scientific Institute Olgettina 60 20132 Milan Italy

Institute of Experimental Endocrinology and Oncology G Salvatore National Research Council Pietro Castellino 111 80131 Naples Italy

Institute of Microbiology Czech Academy of Sciences Vídeňská 1083 14200 Praha 4 Czech Republic

Zobrazit více v PubMed

Joshi  A, Rienks  M, Theofilatos  K. et al.  Systems biology in cardiovascular disease: a multiomics approach. PubMed DOI

Suzuki  Y, Kadomatsu  K, Sakamoto  K. Towards the in vivo identification of protein-protein interactions. PubMed DOI

Kewalramani  N, Emili  A, Crovella  M. State-of-the-art computational methods to predict protein-protein interactions with high accuracy and coverage. PubMed DOI

Vella  D, Zoppis  I, Mauri  G. et al.  From protein-protein interactions to protein co-expression networks: a new perspective to evaluate large-scale proteomic data. PubMed DOI PMC

Di Silvestre  D, Brambilla  F, Lavatelli  F. et al.  The protein network in subcutaneous fat biopsies from patients with AL amyloidosis: more than diagnosis? PubMed DOI PMC

Arfin  S, Kumar  D, Lomagno  A. et al.  Differentially expressed genes, miRNAs and network models: a strategy to shed light on molecular interactions driving HNSCC tumorigenesis. PubMed DOI PMC

Albert  R, Barabśsi  AL. Statistical mechanics of complex networks.

Rotival  M, Petretto  E. Leveraging gene co-expression networks to pinpoint the regulation of complex traits and disease, with a focus on cardiovascular traits. PubMed DOI

Li  M, Zhang  J, Zhang  Z. et al.  Identification of transcriptional pattern related to immune cell infiltration with gene co-expression network in papillary thyroid cancer. PubMed DOI PMC

Walker  CK, Greathouse  KM, Tuscher  JJ. et al.  Cross-platform synaptic network analysis of human entorhinal cortex identifies TWF2 as a modulator of dendritic spine length. PubMed DOI PMC

Zhang  SQ, Pan  SM, Lai  SZ. et al.  Novel plasma proteomic biomarkers for early identification of induction chemotherapy beneficiaries in locoregionally advanced nasopharyngeal carcinoma. PubMed DOI PMC

Johnson  ECB, Carter  EK, Dammer  EB. et al.  Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. PubMed DOI PMC

Shi  L, Winchester  LM, Westwood  S. et al.  Replication study of plasma proteins relating to Alzheimer’s pathology. PubMed DOI

Sebastiani  P, Federico  A, Morris  M. et al.  Protein signatures of centenarians and their offspring suggest centenarians age slower than other humans. PubMed DOI PMC

Meier  F, Geyer  PE, Virreira Winter  S. et al.  BoxCar acquisition method enables single-shot proteomics at a depth of 10,000 proteins in 100 minutes. PubMed DOI

Deutsch  EW, Bandeira  N, Sharma  V. et al.  The ProteomeXchange consortium in 2020: enabling ’big data’ approaches in proteomics. PubMed DOI PMC

Langfelder  P, Horvath  S. WGCNA: an R package for weighted correlation network analysis. PubMed DOI PMC

Vanderwall  D, Suresh  P, Fu  Y. et al.  JUMPn: a streamlined application for protein co-expression clustering and network analysis in proteomics. PubMed DOI PMC

Minadakis  G, Sokratous  K, Spyrou  GM. ProtExA: a tool for post-processing proteomics data providing differential expression metrics, co-expression networks and functional analytics. PubMed DOI PMC

Buljan  M, Banaei-Esfahani  A, Blattmann  P. et al.  A computational framework for the inference of protein complex remodeling from whole-proteome measurements. PubMed DOI PMC

An  G. Closing the scientific loop: Bridging correlation and causality in the petaflop age. PubMed DOI

Cavagna  A, Cimarelli  A, Giardina  I. et al.  Scale-free correlations in starling flocks. PubMed DOI PMC

Holland  DO, Johnson  ME. Stoichiometric balance of protein copy numbers is measurable and functionally significant in a protein-protein interaction network for yeast endocytosis. PubMed DOI PMC

Blumenreich  S, Nehushtan  T, Kupervaser  M. et al.  Large-scale proteomics analysis of five brain regions from Parkinson’s disease patients with a GBA1 mutation. PubMed DOI PMC

Federico  A, Monti  S. Contextualized protein-protein interactions. PubMed DOI PMC

Tsitsiridis  G, Steinkamp  R, Giurgiu  M. et al.  CORUM: The comprehensive resource of mammalian protein complexes-2022. PubMed DOI PMC

Trist  BG, Hare  DJ, Double  KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. PubMed DOI PMC

Ishikawa  K. Multilayered regulation of proteome stoichiometry. PubMed DOI PMC

Henrich  MT, Oertel  WH, Surmeier  DJ. et al.  Mitochondrial dysfunction in Parkinson’s disease - a key disease hallmark with therapeutic potential. PubMed DOI PMC

Ali  MZ, Dholaniya  PS. Oxidative phosphorylation mediated pathogenesis of Parkinson’s disease and its implication via Akt signaling. PubMed

O’Gorman, Tuura  RL, Baumann  CR, Baumann-Vogel  H. Beyond dopamine: GABA, glutamate, and the axial symptoms of Parkinson disease. PubMed DOI PMC

Jang  Y, Pletnikova  O, Troncoso  JC. et al.  Mass spectrometry-based proteomics analysis of human substantia Nigra from Parkinson’s disease patients identifies multiple pathways potentially involved in the disease. PubMed DOI PMC

Wulf  M, Barkovits  K, Schork  K. et al.  Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes. PubMed DOI PMC

Flønes  IH, Toker  L, Sandnes  DA. et al.  Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease. Nat PubMed DOI PMC

Haque  ME, Akther  M, Azam  S. et al.  GPR4 knockout improves the neurotoxin-induced, caspase-dependent mitochondrial apoptosis of the dopaminergic neuronal cell. PubMed PMC

Reeve  AK, Grady  JP, Cosgrave  EM. et al.  Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease. PubMed DOI PMC

Takano  M, Tashiro  E, Kitamura  A. et al.  Prefoldin prevents aggregation of synuclein. PubMed DOI

Skrahin  A, Horowitz  M, Istaiti  M. et al.  GBA1-associated Parkinson’s disease is a distinct entity. PubMed PMC

Faynveitz  A, Lavian  H, Jacob  A. et al.  Proliferation of inhibitory input to the substantia nigra in experimental parkinsonism. PubMed DOI PMC

Huang  L, Ren  Y, Zeng  Z. et al.  Comparative study of striatum GABA concentrations and magnetic resonance spectroscopic imaging in Parkinson’s disease monkeys. PubMed DOI PMC

Smith  Y, Villalba  RM, Raju  DV. Striatal spine plasticity in Parkinson’s disease: pathological or not? PubMed DOI PMC

Vos  M, Lauwers  E, Verstreken  P. Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front Synap PubMed DOI PMC

Mitchell  IJ, Lawson  S, Moser  B. et al.  Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat. PubMed

Zhu  XH, Lee  BY, Tuite  P. et al.  Quantitative assessment of occipital metabolic and energetic changes in Parkinson’s patients, using in vivo 31P MRS-based metabolic imaging at 7T. PubMed DOI PMC

Firbank  MJ, Parikh  J, Murphy  N. et al.  Reduced occipital GABA in Parkinson disease with visual hallucinations. PubMed DOI PMC

Dai  C, Tan  C, Zhao  L. et al.  Glucose metabolism impairment in Parkinson’s disease. PubMed DOI

Tard  C, Demailly  F, Delval  A. et al.  Hypometabolism in posterior and temporal areas of the brain is associated with cognitive decline in Parkinson’s disease. PubMed DOI

Dienel  GA. Brain glucose metabolism: integration of energetics with function. PubMed DOI

Lee  YM, He  W, Liou  YC. The redox language in neurodegenerative diseases: oxidative post-translational modifications by hydrogen peroxide. PubMed DOI PMC

Faienza  F, Rizza  S, Giglio  P. et al.  TRAP1: a metabolic hub linking aging pathophysiology to mitochondrial S-nitrosylation. PubMed DOI PMC

Lee  SH, Chung  KC. USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7. PubMed DOI PMC

Lee  BE, Kim  HY, Kim  HJ. et al.  O-GlcNAcylation regulates dopamine neuron function, survival and degeneration in Parkinson disease. PubMed DOI PMC

Del Giudice  L, Pontieri  P, Aletta  M. et al.  Mitochondrial neurodegenerative diseases: three mitochondrial ribosomal proteins as intermediate stage in the pathway that associates damaged genes with Alzheimer’s and Parkinson’s. PubMed DOI PMC

Kim  AY, Baik  EJ. Glutamate dehydrogenase as a neuroprotective target against neurodegeneration. PubMed DOI

Chen  L, Wang  Y, Huang  J. et al.  Identification of immune-related hub genes in Parkinson’s disease. PubMed DOI PMC

Li  D, Zou  S, Huang  Z. et al.  Isolation and quantification of L1CAM-positive extracellular vesicles on a chip as a potential biomarker for Parkinson’s disease. PubMed DOI PMC

Saini  P, Rudakou  U, Yu  E. et al.  Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson’s disease. PubMed DOI PMC

Buneeva  O, Medvedev  A. Ubiquitin carboxyl-terminal hydrolase L1 and its role in Parkinson’s disease. PubMed DOI PMC

Fathi  E, Yarbro  JM, Homayouni  R. NIPSNAP protein family emerges as a sensor of mitochondrial health. PubMed DOI PMC

Kim  K, Kim  SH, Kim  J. et al.  Glutathione S-transferase omega 1 activity is sufficient to suppress neurodegeneration in a Drosophila model of Parkinson disease. PubMed DOI PMC

Gharibyan  AL, Wasana Jayaweera  S, Lehmann  M. et al.  Endogenous human proteins interfering with amyloid formation. PubMed PMC

Whiten  DR, Cox  D, Horrocks  MH. et al.  Single-molecule characterization of the interactions between extracellular chaperones and toxic synuclein oligomers. PubMed DOI PMC

Yemni  EA, Monies  D, Alkhairallah  T. et al.  Integrated analysis of whole exome sequencing and copy number evaluation in Parkinson’s disease. PubMed DOI PMC

Wang  H, Sun  C, Liang  Y. et al.  Identification of regulatory relationships in Parkinson’s disease. PubMed DOI

Deng  H, Wu  Y, Jankovic  J. TheEIF4G1gene and Parkinson’s disease. PubMed DOI

Chartier-Harlin  MC, Dachsel  J, Vilariño-Güell  C. et al.  Translation initiator EIF4G1 mutations in familial Parkinson disease. PubMed DOI PMC

Harrer  P, Škorvánek  M, Kittke  V. et al.  Dystonia linked to EIF4A2 haploinsufficiency: a disorder of protein translation dysfunction. PubMed DOI

Ma  S, Attarwala  IY, Xie  XQ. SQSTM1/p62: a potential target for neurodegenerative disease. PubMed DOI PMC

Kim  MJ, Jeon  S, Burbulla  LF. et al.  Acid ceramidase inhibition ameliorates synuclein accumulation upon loss of GBA1 function. PubMed DOI PMC

Rahmani  Z, Surabhi  S, Rojo-Cortés  F. et al.  Lamp1 deficiency enhances sensitivity to synuclein and oxidative stress in Drosophila models of Parkinson disease. PubMed DOI PMC

Nguyen  M, Wong  YC, Ysselstein  D. et al.  Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson’s disease. PubMed DOI PMC

De la Casa-Fages  B, Fernśndez-Eulate  G, Gamez  J. et al.  Parkinsonism and spastic paraplegia type 7: expanding the spectrum of mitochondrial parkinsonism. PubMed DOI

Szklarczyk  D, Kirsch  R, Koutrouli  M. et al.  The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. PubMed DOI PMC

Gräßler  J, Koschützki  D, Schreiber  F. CentiLib: comprehensive analysis and exploration of network centralities. PubMed DOI

Ramanathan  M, Zhang  A, Cho  YR. et al. Bridging Centrality: Identifying Bridging Nodes in Scale-Free Networks. KDD '06: Proceedings of the 12th ACM SIGKDD international conference on Knowledge discovery and data mining. New York, NY, (USA): Association for Computing Machinery, 2006. https://api.semanticscholar.org/CorpusID:2706470.

Tosadori  G, Bestvina  I, Spoto  F. et al.  Creating, generating and comparing random network models with NetworkRandomizer. PubMed PMC

Plum  S, Eggers  B, Helling  S. et al.  Proteomic characterization of synaptosomes from human substantia nigra indicates altered mitochondrial translation in Parkinson’s disease. PubMed DOI PMC

Petyuk  VA, Yu  L, Olson  HM. et al.  Proteomic profiling of the substantia nigra to identify determinants of Lewy body pathology and dopaminergic neuronal loss. PubMed DOI PMC

Eisen  MB, Spellman  PT, Brown  PO. et al.  Cluster analysis and display of genome-wide expression patterns. PubMed DOI PMC

Su  L, Liu  G, Guo  Y. et al.  Integration of protein-protein interaction networks and gene expression profiles helps detect pancreatic adenocarcinoma candidate genes. PubMed DOI PMC

Fraenkel  JR, Norman  HHRP, Wallen  E. How to Design and Evaluate Research in Education. New York, NY, (USA): McGraw-Hill Humanities/Social Sciences/Languages, 2011.

Invergo  B, Beltrao  P. Reconstructing phosphorylation signalling networks from quantitative phosphoproteomic data. PubMed DOI PMC